Bioequivalence Study of an Amoxicillin-Clavulanic
NCT01772238
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Respiratory Tract
Interventions
DRUG:
400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml
DRUG:
400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml
Sponsor
GlaxoSmithKline